• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米生物技术:一种不稳定生物分子药物传递的有效方法。

Nanobiotechnology: an efficient approach to drug delivery of unstable biomolecules.

机构信息

Biological Sciences Institute - University of Brasília - Asa Norte, Brasília - Distrito Federal - Brazil. CEP 70910-900.

出版信息

Curr Protein Pept Sci. 2013 Nov;14(7):588-94. doi: 10.2174/1389203711209070632.

DOI:10.2174/1389203711209070632
PMID:23968343
Abstract

Biotechnology and nanotechnology are fields of science that can be applied together to solve a variety of biological issues. In the case of human health, biotechnology attempts to improve advances on the therapy against several diseases. Therapeutic peptides and proteins are promissory molecules for developing new medicines. Gene transfection and RNA interference have been considered important approaches for modern therapy to treat cancer and viral infections. However, because of their instability, these molecules alone cannot be used for in vivo application, since they are easily degraded or presenting a poor efficiency. Nanotechnology can contribute by the development of nanostructured delivery systems to increase the stability and potency of these molecules. Studies involving polymeric and magnetic nanoparticles, dendrimers, and carbon nanotubes have demonstrated a possibility to use these systems as vectors instead of the conventional viral ones, which present adverse effects, such as recombination and immunogenicity. This review presents some possibilities and strategies to efficiently delivery peptides, proteins, gene and RNA interference using nanotechnology approach.

摘要

生物技术和纳米技术是可以结合应用于解决各种生物学问题的科学领域。在人类健康方面,生物技术试图改进对多种疾病的治疗方法。治疗性肽和蛋白质是开发新药的有前途的分子。基因转染和 RNA 干扰已被认为是现代癌症和病毒感染治疗的重要方法。然而,由于它们的不稳定性,这些分子本身不能用于体内应用,因为它们很容易被降解或效率低下。纳米技术可以通过开发纳米结构的递药系统来增加这些分子的稳定性和效力。涉及聚合物和磁性纳米粒子、树枝状大分子和碳纳米管的研究表明,这些系统有可能作为载体替代传统的病毒载体,后者存在重组和免疫原性等不良影响。本文综述了利用纳米技术有效递送肽、蛋白质、基因和 RNA 干扰的一些可能性和策略。

相似文献

1
Nanobiotechnology: an efficient approach to drug delivery of unstable biomolecules.纳米生物技术:一种不稳定生物分子药物传递的有效方法。
Curr Protein Pept Sci. 2013 Nov;14(7):588-94. doi: 10.2174/1389203711209070632.
2
The role of nanobiotechnology in drug discovery.纳米生物技术在药物发现中的作用。
Drug Discov Today. 2005 Nov 1;10(21):1435-42. doi: 10.1016/S1359-6446(05)03573-7.
3
The impact of nanobiotechnology on the development of new drug delivery systems.纳米生物技术对新型药物递送系统发展的影响。
Curr Pharm Biotechnol. 2005 Feb;6(1):3-5. doi: 10.2174/1389201053167158.
4
Nanobiotechnology-based delivery strategies: New frontiers in brain tumor targeted therapies.基于纳米生物技术的递药策略:脑肿瘤靶向治疗的新前沿。
J Control Release. 2016 Oct 28;240:443-453. doi: 10.1016/j.jconrel.2016.03.031. Epub 2016 Mar 23.
5
Nanotechnology: emerging tool for diagnostics and therapeutics.纳米技术:诊断和治疗的新兴工具。
Appl Biochem Biotechnol. 2011 Nov;165(5-6):1178-87. doi: 10.1007/s12010-011-9336-6. Epub 2011 Aug 17.
6
Nanocarriers: promising vehicle for bioactive drugs.纳米载体:生物活性药物的理想载体
Biol Pharm Bull. 2006 Sep;29(9):1790-8. doi: 10.1248/bpb.29.1790.
7
Nanobiotechnology-based drug delivery in brain targeting.基于纳米生物技术的脑靶向给药
Curr Pharm Biotechnol. 2013;14(15):1264-74. doi: 10.2174/1389201015666140608143719.
8
Nanotechnology applications in medicine.纳米技术在医学中的应用。
Med Device Technol. 2003 Jun;14(5):29-31.
9
Dendrimers and the development of new complex nanomaterials for biomedical applications.树状高分子和用于生物医学应用的新型复杂纳米材料的开发。
Curr Med Chem. 2012;19(29):4913-28. doi: 10.2174/0929867311209024913.
10
An Update on Biomedical Application of Nanotechnology for Alzheimer's Disease Diagnosis and Therapy.纳米技术在阿尔茨海默病诊断与治疗中的生物医学应用进展
Drug Res (Stuttg). 2016 Nov;66(11):580-586. doi: 10.1055/s-0042-112811. Epub 2016 Oct 4.

引用本文的文献

1
One Century of Study: What We Learned about and How This Pathogen Contributed to Advances in Antifungal Therapy.一个世纪的研究:我们对这种病原体的了解以及它如何推动抗真菌治疗的进展。
J Fungi (Basel). 2021 Feb 2;7(2):106. doi: 10.3390/jof7020106.
2
Infections and Therapeutic Strategies: Mechanisms of Action for Traditional and Alternative Agents.感染与治疗策略:传统与替代药物的作用机制
Front Microbiol. 2018 Jul 3;9:1351. doi: 10.3389/fmicb.2018.01351. eCollection 2018.
3
Antifungal Therapy for Systemic Mycosis and the Nanobiotechnology Era: Improving Efficacy, Biodistribution and Toxicity.
全身真菌感染的抗真菌治疗与纳米生物技术时代:提高疗效、改善生物分布及降低毒性
Front Microbiol. 2017 Mar 7;8:336. doi: 10.3389/fmicb.2017.00336. eCollection 2017.
4
A snapshot of gene therapy in Latin America.拉丁美洲基因治疗概览。
Genet Mol Biol. 2014 Mar;37(1 Suppl):294-8. doi: 10.1590/s1415-47572014000200015.
5
Early state research on antifungal natural products.抗真菌天然产物的早期研究
Molecules. 2014 Mar 7;19(3):2925-56. doi: 10.3390/molecules19032925.